FTI Consulting elects Elsy Boglioli as independent director, expanding board to ten.

FTI CONSULTING, INC

Elected Elsy Boglioli, age 41, as independent director effective April 7, 2023; board expanded to ten from nine.
She is founder/CEO of Bio-Up, previously EVP/COO of Cellectis and Partner at Boston Consulting Group.
Compensation: prorated $50,000 cash retainer and $250,000 RSU award under non-employee director plan.
Also serves on boards of GenSight Biologics, OSE Immunotherapeutics, TreeFrog Therapeutics, and others.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Elsy Boglioli

independent director

FCN · FTI CONSULTING, INC

Effective: 2023-04-07
Filed: April 11, 2023, 7:59 PM ET

Effective April 7, 2023, the Board of Directors (the “Board”) of FTI Consulting, Inc. (“FTI Consulting”) elected Elsy Boglioli, age 41, as an independent director of FTI Consulting.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Elsy Boglioli was elected as independent director at FTI CONSULTING, INC.

Action: elected
Role: independent director

Exact text from the filing

Effective April 7, 2023, the Board of Directors (the “Board”) of FTI Consulting, Inc. (“FTI Consulting”) elected Elsy Boglioli, age 41, as an independent director of FTI Consulting.

View on SEC.gov

FTI CONSULTING, INC filing history →

Source: SEC EDGAR

accession 0001193125-23-097896

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.